Shares of Clearmind Medicine Inc. (NASDAQ:CMND) are falling Friday after the clinical-stage biotech company shared a key update about its stock listing. What To Know: Clearmind said it received a ...
Vancouver, Canada, March 21, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and ...
Clearmind Medicine (CMND) announced another key milestone in its Phase I/IIa clinical trial for the treatment of Alcohol Use Disorder: the first participant has been enrolled and dosed with CMND-100, ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 p.m. to 4 a.m. ET, Sunday through Thursday, when regular markets are closed.
Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback